465 related articles for article (PubMed ID: 9425842)
1. Silver staining nucleolar organiser region (AgNOR) study in melanocytic skin tumours.
Naik R; Raghuveer CV; Jacob DL
J Indian Med Assoc; 1997 Jul; 95(7):420-1. PubMed ID: 9425842
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing benign and malignant melanocytic lesions with the AgNOR method.
Friedman RJ; Grin CM; Heilman E; Weiser J; Gottlieb GJ; Waldo E; Rigel DS; Kopf AW
Dermatol Clin; 1991 Oct; 9(4):689-93. PubMed ID: 1934643
[TBL] [Abstract][Full Text] [Related]
3. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
Pich A; Chiusa L; Margaria E
Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
[TBL] [Abstract][Full Text] [Related]
4. Argyrophilic nucleolar organizer region counts in malignant melanoma associated with benign intradermal nevus.
Pich A; Aloi F; Margaria E; Tomasini C
Dermatologica; 1991; 183(4):246-50. PubMed ID: 1809585
[TBL] [Abstract][Full Text] [Related]
5. AgNOR (nucleolar organizer regions) staining in malignant melanoma.
Nagatani T; Iemoto G; Miyakawa K; Ichiyama S; Takahashi Y; Uchiyama M; Nakajima H
J Dermatol; 1991 Dec; 18(12):731-5. PubMed ID: 1806604
[TBL] [Abstract][Full Text] [Related]
6. Re-evaluating silver-stained nucleolar organizer regions (AgNORs) in problematic cutaneous melanocytic lesions: a study with quantitation and pattern analysis.
Evans AT; Orrell JM; Grant A
J Pathol; 1991 Sep; 165(1):61-7. PubMed ID: 1955937
[TBL] [Abstract][Full Text] [Related]
7. AgNORs in benign, dysplastic, and malignant melanocytic skin lesions.
Howat AJ; Wright AL; Cotton DW; Reeve S
Am J Dermatopathol; 1990 Apr; 12(2):156-61. PubMed ID: 2331050
[TBL] [Abstract][Full Text] [Related]
8. A critical evaluation of AgNOR counting in benign naevi and malignant melanoma.
Orrell JM; Evans AT; Grant A
J Pathol; 1991 Mar; 163(3):239-44. PubMed ID: 1707452
[TBL] [Abstract][Full Text] [Related]
9. Nucleolar organiser regions in iris melanocytic tumours: an accurate predictor?
Deuble K; McCartney A
Eye (Lond); 1990; 4 ( Pt 5)():743-50. PubMed ID: 1704315
[TBL] [Abstract][Full Text] [Related]
10. The value of nucleolar organizer region staining in the differential diagnosis of borderline melanocytic lesions.
Fallowfield ME; Cook MG
Histopathology; 1989 Mar; 14(3):299-304. PubMed ID: 2468598
[TBL] [Abstract][Full Text] [Related]
11. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
[TBL] [Abstract][Full Text] [Related]
12. Nucleolar organizer regions in pigmented skin lesions. Value in the differential diagnosis of Spitz nevi.
González-Cámpora R; Armas-Padrón JR; Rios-Martín JJ; López-Garrido J; Gómez-Pascual A; Galera-Davidson H
Anal Quant Cytol Histol; 1991 Feb; 13(1):16-22. PubMed ID: 1709022
[TBL] [Abstract][Full Text] [Related]
13. [The nucleolus organizer region in benign and malignant melanocyte lesions of the skin: a quantitative study].
Sementa AR; Gambini C; Borgiani L; Palladino M; Corso M; Canepa M
Pathologica; 1989; 81(1073):231-7. PubMed ID: 2484303
[TBL] [Abstract][Full Text] [Related]
14. [Use of the AgNOR method for the differential diagnosis of tumors and for the quantification of non-neoplastic epidermal hyperproliferation in dermatohistology].
Heinisch G; Barth J
Zentralbl Pathol; 1994 Mar; 140(1):95-101. PubMed ID: 7515680
[TBL] [Abstract][Full Text] [Related]
15. Morphometry and digital AgNOR analysis in cytological imprints of benign, borderline and malignant serous ovarian tumours.
Stemberger-Papić S; Stanković T; Vrdoljak-Mozetic D; Versa-Ostojić D; Krasević M; Stifter S; Audy-Jurković S
Cytopathology; 2006 Dec; 17(6):382-9. PubMed ID: 17168922
[TBL] [Abstract][Full Text] [Related]
16. Quantitative evaluation of AgNORs in bone tumours.
Arora B; Jindal K; Kumar S; Rekhi B; Arora H; Arora DR
Pathology; 2003 Apr; 35(2):106-8. PubMed ID: 12745456
[TBL] [Abstract][Full Text] [Related]
17. Nucleolar organizer regions as discriminators for the diagnosis of well-differentiated adenocarcinoma of the prostate.
Schned AR
Arch Pathol Lab Med; 1993 Oct; 117(10):1000-4. PubMed ID: 8215819
[TBL] [Abstract][Full Text] [Related]
18. AgNOR area measurements differentiate benign and malignant melanocytic lesions more accurately than simple counting.
Gonzalez AP; Kumar D; Sánchez RL
Am J Dermatopathol; 1994 Aug; 16(4):372-6. PubMed ID: 7526724
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of silver binding nucleolar organiser regions (AgNORs) of breast lesions in histological sections and fine needle aspiration smears.
Basu A; Sanyal S; Bhattacharyya A; Bhattacharyya S; Dasgupta S
J Indian Med Assoc; 1997 Aug; 95(8):443-7. PubMed ID: 9492450
[TBL] [Abstract][Full Text] [Related]
20. Nucleolar organizer regions in malignant melanoma and melanocytic nevi. Comparison of two counting methods.
Di Gregorio C; Losi L; Annessi G; Botticelli A
Am J Dermatopathol; 1991 Aug; 13(4):329-33. PubMed ID: 1928617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
